Literature DB >> 1079038

Interaction of plant lectins with purified human lymphocyte populations: binding characteristics and kinetics of proliferation.

D H Boldt, R P MacDermott, E P Jorolan.   

Abstract

With six purified plant lectins as probes of cell surface structure, human T, B, and Null lymphocytes have been examined for cell surface differences. The results of binding experiments with radioiodinated lectins indicate that these three lymphocyte populations, although functionally different, bind equivalent amounts of E- and L-PHA, lentil PHA, Con A, RCA-I, and WGA. Since these lectins are capable of binding to at least four different cell surface oligosaccharides, these data indicate that human T, B, and Null lymphocytes do not differ with respect to surface content of these carbohydrate structures. In addition, all six lectins were investigated for their ability to stimulate DNA synthesis in these human lymphocyte populations. Four of these lectins (E- and L-PHA, lentil PHA, and Con A) were mitogenic for human lymphocytes, whereas RCA-I and WGA failed to stimulate significant DNA synthesis in any lymphocyte population. When incubated with the mitogenic lectins, both B and Null cells displayed a delayed peak of DNA synthesis in comparison to T cells. Thus, despite virtually identical binding characteristics, the lectin-induced mitogenic response exhibited by B and Null cells was markedly different kinetically from that of T cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079038

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.

Authors:  G B Faguet
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

2.  Anchorage and lymphocyte function. Acquisition of spontaneous motile behaviour by human blood lymphocytes and its modulation by concanavalin A.

Authors:  L Wanger; P Otteskog; K G Sundqvist
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

3.  Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation.

Authors:  Christer Eriksson; Lars Frängsmyr; Liza Danielsson Niemi; Vuokko Loimaranta; Ulf Holmskov; Tomas Bergman; Hakon Leffler; Howard F Jenkinson; Nicklas Strömberg
Journal:  Glycoconj J       Date:  2007-01-23       Impact factor: 2.916

4.  Anchorage and lymphocyte function: pattern of spreading distinguishes T- and B-cell chronic lymphocytic leukaemia.

Authors:  K G Sundqvist; K H Robert; G Juliusson; L Wanger; P Biberfeld; P Otteskog
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

5.  Enhanced representation of HL-A antigens on human lymphocytes after mitogenesis induced by phytohemagglutinin or Epstein-Barr virus.

Authors:  J M McCune; R E Humphreys; R R Yocum; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

6.  The role of lymphocyte surface binding sites for wheat germ agglutinin in the negative regulation of cancer patients.

Authors:  T Toge; Y Yamaguchi; A Sawamura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  Stimulation of colony formation and growth factor production of human T lymphocytes by wheat germ lectin.

Authors:  A J Ulmer; W Scholz; H D Flad
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

8.  Immune and hormonal changes in early-stage chronic lymphocytic leukemia patients.

Authors:  H Everaus; J Lehtmaa; E Luik; H Kŏdar
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

9.  Cap formation on lymphocytes from patients with leukemic diseases induced by four different lectins.

Authors:  L G Gürtler; B Emmerich
Journal:  Blut       Date:  1978-04-20

10.  Cell-mediated immunity in Chagas' disease: Alterations induced by treatment with a trypanocidal drug (nifurtimox).

Authors:  R Lelchuk; R L Cardoni; A S Fuks
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.